Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

16.56 +0.19 (+1.16%)

Streaming Delayed Price Updated: 11:25 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

January 12, 2026

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

January 05, 2026

From ADMA Biologics, Inc.

Via GlobeNewswire

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.

Via The Motley Fool

Topics Regulatory Compliance

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Is ADMA Biologics Gaining or Losing Market Support? ↗

August 01, 2025

Via Benzinga

Is ADMA Biologics Gaining or Losing Market Support? ↗

July 02, 2025

Via Benzinga

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗

December 28, 2025

ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.

Via The Motley Fool

Topics Regulatory Compliance

ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate ↗

December 05, 2025

ADMA Biologics exemplifies GARP investing with strong revenue & earnings growth, high profitability, and a reasonable valuation relative to its biotech peers.

Via Chartmill

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

November 05, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why ↗

November 01, 2025

This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why

Via The Motley Fool

How Is The Market Feeling About ADMA Biologics? ↗

June 04, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

ADMA Biologics Earnings Preview ↗

May 06, 2025

Via Benzinga

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

October 29, 2025

Conference Call Scheduled for November 5, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 07, 2025

Via Benzinga

Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket ↗

August 07, 2025

Via Benzinga

Adma Biologics (ADMA) Q2 Revenue Up 14% ↗

August 06, 2025

Via The Motley Fool

Topics Economy

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

August 06, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

July 30, 2025

Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria ↗

June 13, 2025

ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential ↗

June 09, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup ↗

June 07, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock ↗

June 03, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing. ↗

May 09, 2025

Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings ↗

May 08, 2025

Via Benzinga

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits ↗

May 08, 2025

The company makes immunoglobulin products using donated plasma.

Via Investor's Business Daily

Topics Earnings

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 07, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

3 Mid-Cap Medical Stocks Outperforming the Market

May 06, 2025

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

Via MarketBeat

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ADMA Biologics Inc - Common Stock (NQ:ADMA)

All News about ADMA Biologics Inc - Common Stock

Starting at $3.75/week.

Subscribe Today